Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin Weber

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Molecular Modeling|November 17, 2018
A Feynman dispersion correction: a proof of principle for MNDOMaximilian Kriebel, Konstantin Weber, Timothy Clark
Nature Communications|February 13, 2026
Tracking country-level mitigation progress using NGHGI-consistent carbon budgetsKonstantin Weber, Cyril Brunner, Reto Knutti
Regulatory Toxicology and Pharmacology : RTP|March 1, 2016
Is sunitinib a Narrow Therapeutic Index Drug? - A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissuesBodo Haas, Konstantin Weber-Lassalle, Roland Frötschl, et al.
International Journal of Medical Microbiology : IJMM|March 16, 2012
Revisiting the genomes of the Staphylococcus aureus strains NCTC 8325 and RN4220Anne Berscheid, Peter Sass, Konstantin Weber-Lassalle, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2016
Substrate-Modulated Reductive Graphene FunctionalizationRicarda A Schäfer, Konstantin Weber, Maria Koleśnik-Gray, et al.
Nature|December 20, 2013
Dislocations in bilayer grapheneBenjamin Butz, Christian Dolle, Florian Niekiel, et al.
Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
BMC Cancer|June 27, 2022
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriersJulika Borde, Yael Laitman, Britta Blümcke, et al.
International Journal of Cancer|November 27, 2018
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriersKristina Klaschik, Jan Hauke, Guido Neidhardt, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Molecular Modeling|November 17, 2018
A Feynman dispersion correction: a proof of principle for MNDOMaximilian Kriebel, Konstantin Weber, Timothy Clark
Nature Communications|February 13, 2026
Tracking country-level mitigation progress using NGHGI-consistent carbon budgetsKonstantin Weber, Cyril Brunner, Reto Knutti
Regulatory Toxicology and Pharmacology : RTP|March 1, 2016
Is sunitinib a Narrow Therapeutic Index Drug? - A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissuesBodo Haas, Konstantin Weber-Lassalle, Roland Frötschl, et al.
International Journal of Medical Microbiology : IJMM|March 16, 2012
Revisiting the genomes of the Staphylococcus aureus strains NCTC 8325 and RN4220Anne Berscheid, Peter Sass, Konstantin Weber-Lassalle, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2016
Substrate-Modulated Reductive Graphene FunctionalizationRicarda A Schäfer, Konstantin Weber, Maria Koleśnik-Gray, et al.
Nature|December 20, 2013
Dislocations in bilayer grapheneBenjamin Butz, Christian Dolle, Florian Niekiel, et al.
Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.
Journal of the National Cancer Institute|December 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian CancerKonstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, et al.
BMC Cancer|June 27, 2022
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriersJulika Borde, Yael Laitman, Britta Blümcke, et al.
International Journal of Cancer|November 27, 2018
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriersKristina Klaschik, Jan Hauke, Guido Neidhardt, et al.
Pageof 2